Proton Pump Inhibitor Use and Enteric Infections

被引：67

作者：

Dial, M. Sandra ^{[1
]}

机构：

[1] McGill Univ, Jewish Gen Hosp, Montreal Chest Inst & SMBD, Dept Med, Montreal, PQ H2X 2P4, Canada

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷

关键词：

DIFFICILE-ASSOCIATED-DIARRHEA; COMMUNITY-ACQUIRED PNEUMONIA; GASTRIC-ACID SUPPRESSANTS; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; HOSPITALIZED-PATIENTS; BACTERIAL OVERGROWTH; CAMPYLOBACTER GASTROENTERITIS; GASTROINTESTINAL-TRACT; FLUOROQUINOLONE USE;

D O I：

10.1038/ajg.2009.46

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) are very commonly prescribed drugs and are routinely used in the chronic management of gastro-esophageal reflux disease. Concerns have been raised about the possible association of PPIs with enteric infections. This article reviews the studies that have examined the associations of proton pump inhibitors in particular, and enteric infections.

引用

页码：S10 / S16

页数：7

共 94 条

[1] Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro [J].

Agastya, G ;

West, BC ;

Callahan, JM .

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2000, 22 (02) :357-372

[2]

Akhtar AJ, 2007, J NATL MED ASSOC, V99, P500

[3] Traveller's diarrhoea [J].

Al-Abri, SS ;

Beeching, NJ ;

Nye, FJ .

LANCET INFECTIOUS DISEASES, 2005, 5 (06) :349-360

[4]

Al-Tureihi Farrah Ibrahim J, 2005, J Am Med Dir Assoc, V6, P105, DOI 10.1016/j.jamda.2005.01.003

[5] Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium difficile-Associated Diarrhea in Hospitalized Patients [J].

Aseeri, Mohammed ;

Schroeder, Todd ;

Kramer, Joan ;

Zackula, Rosalee .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (09) :2308-2313

[6] Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus [J].

Asha, N. J. ;

Tompkins, D. ;

Wilcox, M. H. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2785-2791

[7] Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment [J].

Bardhan, KD ;

Bishop, AE ;

Polak, JM ;

Romanska, HM ;

Rowland, A ;

Thompson, M ;

Morris, P ;

Schaefer-Preuss, S ;

Luehmann, R ;

McCaldin, B .

DIGESTIVE AND LIVER DISEASE, 2005, 37 (01) :10-22

[8] The gastric secretion - Its bactericidal value to man - With a report of bactericidal experiments [J].

Bartle, HJ ;

Harkins, MJ .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1925, 169 :373-388

[9] Case-control study of antibiotic use and subsequent Clostridium difficile -: Associated diarrhea in hospitalized patients [J].

Baxter, Roger ;

Ray, G. Thomas ;

Fireman, Bruce H. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (01) :44-50

[10] Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit [J].

Beaulieu, Mathieu ;

Williamson, David ;

Pichette, Gilbert ;

Lachaine, Jean .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (11) :1305-1307

← 1 2 3 4 5 6 7 8 9 10 →